Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis

Fig. 3

Forest plots of response rates in studies of 131I-MIBG combined with other therapies. A: Forest plot of objective response rates in studies of 131I-MIBG combined with other therapies. B: Forest plot of SD rates in studies of 131I-MIBG combined with other therapies. C: Forest plot of PD rates in studies of 131I-MIBG combined with other therapies. D: Forest plot of MR rates in studies of 131I-MIBG combined with other therapies.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us